Recently, we discussed the ongoing controversy over the invalidation of some of Myriad Genetics' breast cancer gene patents. The controversy continues to rage in both traditional media and the blogosphere.
One thing that seems quite clear is the impressive polarization of opinions supporting either side in this case, which likely will end up in the Supreme Court eventually.
For those who are still seeking to understand the perspective of one side or the other in this case, Genetic Alliance is presenting a webinar this Friday, April 30, which should be well worth your time:
Genetic Alliance Webinar
The Myriad Gene Patent Case - What Does it Mean, and Why Does it Matter?
Friday, April 30, 2010, 12:00pm - 1:30pm Eastern Time
Presenters
John Conley - Professor of Law, University of North Carolina - Chapel Hill
Joshua Sarnoff - Professor & Associate Director, Glushko-Samuelson Intellectual Property Law Clinic, Washington College of Law, American University
Hans Sauer - Associate General Counsel for Intellectual Property, BIO
Ann Waldo - Senior Counsel, Genetic Alliance
The webinar is free. Click here to register for it at the Genetic Alliance website. It should be a very interesting discussion.
Comments